BEBO Health SA (MLBBO) - Net Assets
Based on the latest financial reports, BEBO Health SA (MLBBO) has net assets worth €520.09K EUR (≈ $608.04K USD) as of December 2021. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€4.94 Million ≈ $5.78 Million USD) and total liabilities (€4.42 Million ≈ $5.17 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read BEBO Health SA (MLBBO) total liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €520.09K |
| % of Total Assets | 10.52% |
| Annual Growth Rate | 121.39% |
| 5-Year Change | 2125.3% |
| 10-Year Change | N/A |
| Growth Volatility | 561.63 |
BEBO Health SA - Net Assets Trend (2019–2024)
This chart illustrates how BEBO Health SA's net assets have evolved over time, based on quarterly financial data. Also explore total assets of BEBO Health SA for the complete picture of this company's asset base.
Annual Net Assets for BEBO Health SA (2019–2024)
The table below shows the annual net assets of BEBO Health SA from 2019 to 2024. For live valuation and market cap data, see MLBBO market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €8.06 Million ≈ $9.42 Million |
+0.16% |
| 2023-12-31 | €8.04 Million ≈ $9.40 Million |
+0.15% |
| 2022-12-31 | €8.03 Million ≈ $9.39 Million |
+1444.14% |
| 2021-12-31 | €520.09K ≈ $608.04K |
+43.67% |
| 2020-12-31 | €362.01K ≈ $423.22K |
+139.40% |
| 2019-12-31 | €151.21K ≈ $176.78K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to BEBO Health SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 732.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €426.19K | 5.29% |
| Common Stock | €348.00K | 4.32% |
| Other Components | €7.28 Million | 90.39% |
| Total Equity | €8.06 Million | 100.00% |
BEBO Health SA Competitors by Market Cap
The table below lists competitors of BEBO Health SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Windtree Therapeutics Inc
NASDAQ:WINT
|
$579.79K |
|
Cora Gold Limited
LSE:CORA
|
$580.56K |
|
R.E.A. Holdings plc
LSE:RE
|
$581.29K |
|
Tupperware Brands Corporation
NYSE:TUPBQ
|
$581.63K |
|
PROMIS NEUROSCIENCES
F:23J0
|
$576.86K |
|
Medivie Therapeutic Ltd
TA:MDVI
|
$576.17K |
|
STV Group plc
LSE:STVG
|
$575.38K |
|
Oxbridge Re Holdings Equity Warrant
NASDAQ:OXBRW
|
$574.50K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BEBO Health SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 8,042,667 to 8,055,712, a change of 13,045 (0.2%).
- Net income of 81,331 contributed positively to equity growth.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €81.33K | +1.01% |
| Other Changes | €-68.29K | -0.85% |
| Total Change | €- | 0.16% |
Book Value vs Market Value Analysis
This analysis compares BEBO Health SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.06x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 21.86x to 0.06x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | €0.01 | €0.23 | x |
| 2020-12-31 | €0.02 | €0.23 | x |
| 2021-12-31 | €0.36 | €0.23 | x |
| 2023-12-31 | €3.70 | €0.23 | x |
| 2024-12-31 | €3.70 | €0.23 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BEBO Health SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.01%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.31%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 1.38x
- Recent ROE (1.01%) is below the historical average (17.57%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 33.87% | 5.01% | 4.97x | 1.36x | €36.09K |
| 2020 | 58.23% | 10.01% | 2.03x | 2.86x | €174.59K |
| 2021 | 11.17% | 1.06% | 1.10x | 9.50x | €6.07K |
| 2022 | 1.01% | 1.31% | 0.71x | 1.10x | €-721.76K |
| 2023 | 0.15% | 0.23% | 0.46x | 1.35x | €-792.54K |
| 2024 | 1.01% | 1.31% | 0.56x | 1.38x | €-724.24K |
Industry Comparison
This section compares BEBO Health SA's net assets metrics with peer companies in the Specialty Retail industry.
Industry Context
- Industry: Specialty Retail
- Average net assets among peers: $196,568,468
- Average return on equity (ROE) among peers: -76.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BEBO Health SA (MLBBO) | €520.09K | 33.87% | 8.50x | $579.76K |
| Emova Group SA (ALEMV) | $3.59 Million | -611.54% | 15.09x | $12.88 Million |
| Hydrogen Refueling Solutions (ALHRS) | $-303.00K | 0.00% | 0.00x | $26.83 Million |
| Hunyvers SA (ALHUN) | $26.77 Million | 14.79% | 2.20x | $28.95 Million |
| Upergy (ALUPG) | $12.49 Million | -13.13% | 1.32x | $7.79 Million |
| Fnac Darty SA (FNAC) | $397.00 Million | -35.69% | 3.35x | $1.03 Billion |
| TROC DE L'ILE SA (MLTRO) | $10.36 Million | 13.53% | 1.37x | $1.67 Million |
| Lagardere SCA (MMB) | $1.09 Billion | 15.40% | 7.73x | $2.69 Billion |
| Passat Société Anonyme (PSAT) | $31.63 Million | 4.97% | 0.24x | $17.14 Million |
About BEBO Health SA
BEBO Health SA operates an e-commerce portal for products related to health, sports, and well-being. The company was founded in 2019 and is based in Geneva, Switzerland. BEBO Health SA operates as a subsidiary of CES Management SA.